Novartis dials up 2024 sales outlook, preps for key expansions of 3 cancer drugs aliu Tue, 04/23/2024 – 15:46 More: Novartis dials up 2024 sales outlook, preps for key expansions of 3 cancer drugs Source: fierce
read moreEli Lilly inks deal to acquire Nexus manufacturing plant in Wisconsin as Mounjaro and Zepbound shortages drag on fkansteiner Tue, 04/23/2024 – 15:10 More: Eli Lilly inks deal to acquire Nexus manufacturing plant in Wisconsin as Mounjaro and Zepbound shortages
read moreNew kid on The Bloc: Ogilvy, McCann alum Eduardo Basque joins as associate creative director apark Tue, 04/23/2024 – 11:25 More: New kid on The Bloc: Ogilvy, McCann alum Eduardo Basque joins as associate creative director Source: fierce
read moreNovartis ‘actively’ reviewing relationships with Chinese contractors amid US biosecurity crackdown: CFO fkansteiner Tue, 04/23/2024 – 11:10 More: Novartis 'actively' reviewing relationships with Chinese contractors amid US biosecurity crackdown: CFO Source: fierce
read moreAnother delay for Abeona’s topical gene therapy pz-cel as FDA sends out a rejection kdunleavy Tue, 04/23/2024 – 11:04 More: Another delay for Abeona's topical gene therapy pz-cel as FDA sends out a rejection Source: fierce
read moreSevere acute malnutrition is responsible for nearly half of all child deaths globally and affects 17 million children annually More: Trial reveals mechanisms that contribute to impact of malnutrition and HIV infection Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals